According to the American Diabetes Association, diabetes affects 30 million Americans, including 8.1 million people who are undiagnosed. Another 86 million more—one in three adults—have prediabetes and 15-30 percent will develop diabetes within five years without change.
The Scary Statistics
- People with type 2 diabetes have more than two times the risk for developing heart disease
- People with diabetes live 7-8 years less
- Two out of three deaths in people with type 2 diabetes are attributed to cardiovascular disease
- Less than half of people with diabetes are aware of their risk of cardiovascular disease. This lack of awareness prevents people with diabetes and their health care providers from addressing risks and improving health.
The Partnership to Fight Chronic Disease states that “the increased co-occurrence of diabetes and cardiovascular disease demands greater awareness to save lives and health care dollars.”
At Tria Health, that’s precisely what we do—we manage the whole patient, and discuss all their conditions, prescription medications, over-the-counter medications and their lifestyle. Our pharmacists educate their patients about their medications and make recommendations to the patients and their prescribing physicians to improve clinical outcomes.
A Tria Health Patient Success Story
During an initial pharmacist consultation, it was documented that the patient’s HgbA1c was too high – indicating poorly controlled Diabetes. In addition, the patient had significant financial difficulties affording certain medications increasing medication non-adherence. The patient was initially prescribed Metformin, but stopped taking the medication due to stomach problems without replacing it with any other diabetes medication. The pharmacist recommended a prescription of Glimepiride since it is inexpensive, very effective, and generally well tolerated. The patient’s physician agreed with the recommendation and the patient has achieved a HgbA1c of 8% in one year
In addition, the Tria pharmacist recommended switching from brand-named Benicar-HCT, a blood pressure medication, to a similarly available generic blood pressure medication called Losartan-HCTZ. The generic version saved the member $40 every 30 days and the patient’s blood pressure remains well controlled on Losartan-HCTZ.
The patient initially had success and then set-backs with smoking cessation. The Tria pharmacist worked with them to achieve sustained smoking cessation and improved health by identifying appropriate therapies and by providing ongoing education and coaching.
This success story illustrates that by managing the whole patient, and all their conditions, can and will improve clinical and financial outcomes.